Bank of New York Mellon’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-124,767
| Closed | -$12.2M | – | 4324 |
|
|
2015
Q1 | $12.2M | Buy |
124,767
+13,582
| +12% | +$1.32M | ﹤0.01% | 1839 |
|
|
2014
Q4 | $10.3M | Buy |
111,185
+1,098
| +1% | +$102K | ﹤0.01% | 1895 |
|
|
2014
Q3 | $7.57M | Buy |
110,087
+6,506
| +6% | +$447K | ﹤0.01% | 2069 |
|
|
2014
Q2 | $10.9M | Sell |
103,581
-6,141
| -6% | -$644K | ﹤0.01% | 1875 |
|
|
2014
Q1 | $9.1M | Buy |
109,722
+12,643
| +13% | +$1.05M | ﹤0.01% | 1960 |
|
|
2013
Q4 | $6.28M | Buy |
97,079
+18,762
| +24% | +$1.21M | ﹤0.01% | 2161 |
|
|
2013
Q3 | $4.97M | Buy |
78,317
+7,951
| +11% | +$504K | ﹤0.01% | 2255 |
|
|
2013
Q2 | $2.95M | Buy |
+70,366
| New | +$2.95M | ﹤0.01% | 2531 |
|